Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-06 5:08 pm Unchanged | 13G | CITIUS ONCOLOGY INC. CTOR | Hudson Bay Capital Management LP | 0 0.000% | 0 (Unchanged) | View |
| 2024-09-05 09:23 am Sale | 13G | CITIUS ONCOLOGY INC. CTOR | WOLVERINE ASSET MANAGEMENT LLC | 0 0.000% | -567,211 (Position Closed) | View |
| 2024-08-16 4:34 pm Purchase | 13D | CITIUS ONCOLOGY INC. CTOR | Citius Pharmaceuticals Inc. CTXR | 66,049,615 92.600% | 66,049,615 (New Position) | View |
| 2024-08-15 12:53 pm Purchase | 13D | CITIUS ONCOLOGY INC. CTOR | 10XYZ Holdings LP | 1,978,954 2.800% | 1,978,954 (New Position) | View |
| 2024-03-07 4:06 pm Sale | 13G | CITIUS ONCOLOGY INC. CTOR | Karpus Management Inc. | 0 0.000% | -504,610 (Position Closed) | View |
| 2024-02-13 8:09 pm Purchase | 13G | CITIUS ONCOLOGY INC. CTOR | MIZUHO FINANCIAL GROUP INC MFG | 522,030 5.840% | 522,030 (New Position) | View |
| 2024-02-13 4:07 pm Purchase | 13G | CITIUS ONCOLOGY INC. CTOR | Karpus Management Inc. | 504,610 5.640% | 504,610 (New Position) | View |
| 2024-02-08 4:07 pm Purchase | 13G | CITIUS ONCOLOGY INC. CTOR | WOLVERINE ASSET MANAGEMENT LLC | 567,211 6.340% | 567,211 (New Position) | View |
| 2024-02-05 3:37 pm Sale | 13G | CITIUS ONCOLOGY INC. CTOR | Space Summit Capital LLC | 0 0.000% | -441,678 (Position Closed) | View |
| 2023-02-14 3:32 pm Sale | 13G | CITIUS ONCOLOGY INC. CTOR | Feis Lawrence | 339,321 3.800% | -202,685 (-37.40%) | View |
| 2023-02-10 4:39 pm Purchase | 13G | CITIUS ONCOLOGY INC. CTOR | Hudson Bay Capital Management LP | 500,000 5.590% | 500,000 (New Position) | View |
| 2023-02-08 08:39 am Purchase | 13G | CITIUS ONCOLOGY INC. CTOR | Feis Lawrence | 542,006 6.060% | 542,006 (New Position) | View |
| 2023-02-07 7:48 pm Sale | 13G | CITIUS ONCOLOGY INC. CTOR | Space Summit Capital LLC | 441,678 6.690% | -153,322 (-25.77%) | View |
| 2022-10-28 4:59 pm Purchase | 13D | CITIUS ONCOLOGY INC. CTOR | 10XYZ Holdings LP | 2,044,000 22.860% | 2,044,000 (New Position) | View |
| 2022-10-20 10:50 am Purchase | 13G | CITIUS ONCOLOGY INC. CTOR | Feis Lawrence | 508,819 7.710% | 508,819 (New Position) | View |
| 2022-10-19 3:48 pm Purchase | 13G | CITIUS ONCOLOGY INC. CTOR | Space Summit Capital LLC | 595,000 9.920% | 595,000 (New Position) | View |